157 related articles for article (PubMed ID: 20444934)
1. Treatment of persistent or recurrent papillary carcinoma of the thyroid--the good, the bad, and the unknown.
Udelsman R
J Clin Endocrinol Metab; 2010 May; 95(5):2061-3. PubMed ID: 20444934
[No Abstract] [Full Text] [Related]
2. (18)F-FDG PET discovered an elusive cervical inflammatory pseudotumor associated with a papillary thyroid cancer.
Modesto J; Gardeazabal I; Santos AM; Galofré JC
Endocrinol Nutr; 2014; 61(6):338-40. PubMed ID: 24721020
[No Abstract] [Full Text] [Related]
3. Papillary thyroid cancer.
Sosa JA; Udelsman R
Surg Oncol Clin N Am; 2006 Jul; 15(3):585-601. PubMed ID: 16882499
[TBL] [Abstract][Full Text] [Related]
4. Increased I-131 uptake in local recurrence and distant metastases after second treatment with retinoic acid.
Koerber C; Schmutzler C; Rendl J; Koehrle J; Griesser H; Simon D; Reiners C
Clin Nucl Med; 1999 Nov; 24(11):849-51. PubMed ID: 10551465
[TBL] [Abstract][Full Text] [Related]
5. [Papillary cancer of the thyroid: biological behaviour and therapeutic planning (author's transl)].
Spreafico G; Colombo L; Puricelli G
Radiol Med; 1978 Sep; 64(9):1005-20. PubMed ID: 749025
[TBL] [Abstract][Full Text] [Related]
6. An unusual presentation of diffuse sclerosing variant of papillary thyroid carcinoma.
Regalbuto C; Tumminia A; Malandrino P; Salamone S; Pezzino V
J Endocrinol Invest; 2010 Jun; 33(6):434-5. PubMed ID: 20631495
[No Abstract] [Full Text] [Related]
7. A proposition for the use of radioiodine in WDTC management.
Bourgeois P
J Nucl Med; 2009 Feb; 50(2):328-9; author reply 329-30. PubMed ID: 19164221
[No Abstract] [Full Text] [Related]
8. Ultrasonographic findings of a newly detected nodule on the thyroid bed in postoperative patients for thyroid carcinoma: correlation with the results of ultrasonography-guided fine-needle aspiration biopsy.
Lee JH; Lee HK; Lee DH; Choi CG; Gong G; Shong YK; Kim SJ
Clin Imaging; 2007; 31(2):109-13. PubMed ID: 17320777
[TBL] [Abstract][Full Text] [Related]
9. Classification of papillary thyroid microcarcinoma according to size and fine-needle aspiration cytology: Behavior and therapeutic implications.
Friguglietti CU; Dutenhefner SE; Brandão LG; Kulcsar MA
Head Neck; 2011 May; 33(5):696-701. PubMed ID: 20737499
[TBL] [Abstract][Full Text] [Related]
10. Management of papillary thyroid cancer patients in absence of postoperative radioiodine remnant ablation: tailoring follow-up by neck sonography.
Durante C; Filetti S
J Clin Endocrinol Metab; 2011 Oct; 96(10):3059-61. PubMed ID: 21795452
[No Abstract] [Full Text] [Related]
11. Radioiodine therapy for papillary and follicular thyroid carcinoma.
Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
[TBL] [Abstract][Full Text] [Related]
12. Utility of PET/neck MRI digital fusion images in the management of recurrent or persistent thyroid cancer.
Seiboth L; Van Nostrand D; Wartofsky L; Ousman Y; Jonklaas J; Butler C; Atkins F; Burman K
Thyroid; 2008 Feb; 18(2):103-11. PubMed ID: 18279011
[TBL] [Abstract][Full Text] [Related]
13. Papillary carcinoma simultaneously involving thyroid, neck lymph-nodes, ovary and bone marrow.
Giovanella L; Suriano S; Ceriani L; Verburg FA
Nuklearmedizin; 2010; 49(6):N66-8. PubMed ID: 21140033
[No Abstract] [Full Text] [Related]
14. Combined use of perioperative TSH-stimulated (18)F-FDG PET/CT imaging and gamma probe radioguided surgery to localize and verify resection of iodine scan-negative recurrent thyroid carcinoma.
Agrawal A; Hall NC; Ringel MD; Povoski SP; Martin EW
Laryngoscope; 2008 Dec; 118(12):2190-4. PubMed ID: 18978509
[No Abstract] [Full Text] [Related]
15. Recombinant human TSH changes the multidisciplinary approach to patients with differentiated thyroid carcinoma. Two-year experience.
Giusti M; Zoccola R; Guazzini B; Molinari E; Valenti S; Villa G; Bertolazzi L; Minuto F
Minerva Endocrinol; 2003 Sep; 28(3):191-203. PubMed ID: 14605601
[TBL] [Abstract][Full Text] [Related]
16. Esophageal diverticulum presenting as metastatic thyroid mass on iodine-131 scintigraphy.
Rashid K; Johns W; Chasse K; Walker M; Gupta SM
Clin Nucl Med; 2006 Jul; 31(7):405-8. PubMed ID: 16785810
[No Abstract] [Full Text] [Related]
17. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
Vassilopoulou-Sellin R; Schultz PN; Haynie TP
Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
[TBL] [Abstract][Full Text] [Related]
18. Cervicomediastinal magnetic resonance imaging in persistent or recurrent papillary thyroid carcinoma: clinical use and limits.
Toubert ME; Cyna-Gorse F; Zagdanski AM; Noel-Wekstein S; Cattan P; Billotey C; Sarfati E; Rain JD
Thyroid; 1999 Jun; 9(6):591-7. PubMed ID: 10411122
[TBL] [Abstract][Full Text] [Related]
19. Papillary thyroid carcinoma: the impact of therapy in 576 patients.
Mazzaferri EL; Young RL; Oertel JE; Kemmerer WT; Page CP
Medicine (Baltimore); 1977 May; 56(3):171-96. PubMed ID: 859443
[No Abstract] [Full Text] [Related]
20. Cytologic features of infarcted thyroid papillary carcinoma induced by fine needle aspiration.
Jang SM; Jun YJ; Na W; Jang KS; Paik SS
Acta Cytol; 2010; 54(5 Suppl):1082-3. PubMed ID: 21053614
[No Abstract] [Full Text] [Related]
[Next] [New Search]
